Merlin is Director at Bioscience Valuation BSV GmbH, a globally operating Life Science Assessment and Financial Analysis company based in Europe. At BSV, Merlin supervises comprehensive assessments and valuations of life science investment opportunities at all stages and is also responsible for Corporate Development.
Before joining BSV, Merlin worked as a physician in various hospitals. He holds a BA in Psychology from Stanford University (USA), a Master of Global Health from the University of Barcelona (Spain), and an MD from Heidelberg University (Germany).
Merlin has diverse, interdisciplinary, and global experience in the healthcare sector. Born with a natural interest in science, he began exploring the business side of biotech at the age of 17 when he performed his first financial analysis of Genentech. While in college, collaborations with nonprofits in Colombia, Mexico, and Bolivia stimulated his interest in global health, a field in which he conducts research to this day.
Before joining BSV, Merlin worked as a physician in various hospitals. He holds a BA in Psychology from Stanford University (USA), a Master of Global Health from the University of Barcelona (Spain), and an MD from Heidelberg University (Germany).
Merlin has diverse, interdisciplinary, and global experience in the healthcare sector. Born with a natural interest in science, he began exploring the business side of biotech at the age of 17 when he performed his first financial analysis of Genentech. While in college, collaborations with nonprofits in Colombia, Mexico, and Bolivia stimulated his interest in global health, a field in which he conducts research to this day.
Speaking In
1:45 PM - 2:45 PM
Tuesday, June 6
